Hemogenyx Pharmaceuticals PLC Sustainability Reports
Hemogenyx Pharmaceuticals PLC is a clinical-stage biotechnology company developing novel therapies and treatments for blood diseases and cancers. Its focus includes the discovery and development of cell therapies, such as CAR-T treatments, and immunotherapies to improve bone marrow transplantation.
Sector: Professional & technical services
Country: United Kingdom
Exchange: London Stock Exchange
LEI: 2138008L93GYU5GN6179
FIGI: BBG00BDKH4C6
8 reports from 2017 to 2025
- Hemogenyx Pharmaceuticals PLC 2025 Annual Report & Financial Statements
- Hemogenyx Pharmaceuticals PLC 2024 Annual Report & Financial Statements
- Hemogenyx Pharmaceuticals PLC 2023 Annual Report & Financial Statements
- Hemogenyx Pharmaceuticals PLC 2022 Annual Report & Financial Statements
- Hemogenyx Pharmaceuticals PLC 2021 Annual Report & Financial Statements
